Capricor Therapeutics
CAPR
#5653
Rank
S$1.77 B
Marketcap
S$30.69
Share price
-1.62%
Change (1 day)
142.85%
Change (1 year)

Capricor Therapeutics (CAPR) - Net assets

Net assets on the balance sheet as of March 2026 : S$0.36 Billion

According to Capricor Therapeutics 's latest financial reports the company has S$0.36 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Capricor Therapeutics - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2024-12-31$S$0.19 B562.39%
2023-12-31$S$29.84 M88.92%
2022-12-31$S$15.8 M-62.74%
2021-12-31$S$42.4 M13.67%
2020-12-31$S$37.3 M304.6%
2019-12-31$S$9.22 M46.23%
2018-12-31$S$6.3 M-58.01%
2017-12-31$S$15.01 M-359.17%
2016-12-31$-S$5.8 Million296.98%
2015-12-31$-S$1.46 Million-82.32%
2014-12-31$-S$8.26 Million1118.37%
2013-12-31$-S$0.68 Million-111.32%
2012-12-31$S$5.98 M456.35%
2011-12-31$S$1.07 M-67.84%
2010-12-31$S$3.34 M-20.1%
2009-12-31$S$4.18 M-42.64%
2008-12-31$S$7.29 M-66.63%
2007-12-31$S$21.87 M-10683.47%
2006-12-31$-S$0.21 Million59.91%
2005-12-31$-S$0.13 Million34.82%
2004-12-31$-S$0.1 Million38.68%
2003-12-31$-S$0.07 Million62.41%
2002-12-31$-S$0.05 Million157.12%
2001-12-31$-S$0.02 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
S$105.16 B 29,029.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$4.41 B 1,122.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$1.08 Billion-396.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$0.59 B 63.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S$0.51 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$4.62 M-98.72%๐Ÿ‡บ๐Ÿ‡ธ USA